Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve

Na Xu1,2, Christina M Alfieri1, Yang Yu3

  • 1Division of Molecular Cardiovascular Biology, the Heart Institute (N.X., C.M.A., K.E.Y.), Cincinnati Children's Hospital Medical Center, OH.

Abstract

Insights

Wnt signaling initiates mitral valve disease in Marfan syndrome by causing valve thickening and inflammation. Early intervention targeting Wnt signaling can prevent disease onset, but is ineffective once the condition progresses.

Area of Science:

  • Cardiovascular Biology
  • Genetics
  • Molecular Biology

Background:

  • Myxomatous valve disease (MVD) is a leading cause of mitral regurgitation and heart failure.
  • MVD in Marfan syndrome mouse models involves valve thickening and degeneration, with unclear mechanisms.
  • Understanding MVD progression is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of Wnt signaling in the initiation and progression of MVD in a Marfan syndrome mouse model.
  • To determine if inhibiting Wnt signaling can prevent or reverse MVD.
  • To identify potential therapeutic targets for early MVD intervention.

Main Methods:

  • Utilized Fibrillin 1 (Fbn1) mutant mice and TCF/Lef-lacZ reporter mice to study Wnt signaling.
  • Performed single-cell RNA sequencing on mitral valves from wild-type and Fbn1 mutant mice.
  • Inhibited Wnt signaling using Dkk1 in a conditional knockout model, administered at different disease stages.

Main Results:

  • Wnt signaling activation precedes immune cell infiltration in MVD progression.
  • Early Wnt inhibition (1 month) prevented MVD initiation, reducing valve thickening and macrophage infiltration.
  • Late Wnt inhibition (2 months) did not prevent established MVD progression.

Conclusions:

  • Wnt signaling is critical for MVD initiation and early inflammation but not for later disease progression.
  • Wnt signaling's role in MVD is time-dependent, highlighting the importance of early therapeutic intervention.
  • Targeting Wnt signaling early offers a promising strategy for congenital MVD in Marfan syndrome.